| author name | recommending | commenting | favorite | papers | recom. | cited | |
|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 173 | 0 | 1430 | [Update] | |
| 0 | 0 | 0 | 1 | 0 | 0 | [Update] | |
| 0 | 0 | 0 | 15 | 0 | 20 | [Update] | |
| 0 | 0 | 0 | 1 | 0 | 0 | [Update] | |
| 0 | 0 | 0 | 4 | 0 | 3 | [Update] | |
| 0 | 0 | 0 | 25 | 0 | 212 | [Update] | |
| 0 | 0 | 0 | 1 | 0 | 0 | [Update] |
Latest Paper:
Christina Bauerschmidt,
Cecilia Arrichiello,
Susanne Burdak-Rothkamm,
Michael Woodcock,
Mark A Hill,
David L Stevens,
Kai Rothkamm
Gray Institute for Radiation Oncology and Biology, University of Oxford, Oxford OX3 7DQ, Gray Cancer Institute, Mount Vernon Hospital, Northwood, Middlesex HA6 2JR and Health Protection Agency, Radiation Protection Division, Chilton, Didcot, OX11 0RQ, UK.
The cohesin protein complex holds sister chromatids together after synthesis until mitosis. It also contributes to post-replicative DNA repair in yeast and higher eukaryotes and accumulates at sites of laser-induced damage in human cells. Our goal was to determine whether the cohesin subunits SMC1 and Rad21 contribute to DNA double-strand break repair in X-irradiated human cells in the G2 phase of the cell cycle. RNA interference-mediated depletion of SMC1 sensitized HeLa cells to X-rays. Repair of radiation-induced DNA double-strand breaks, measured by gammaH2AX/53BP1 foci analysis, was slower in SMC1- or Rad21-depleted cells than in controls in G2 but not in G1. Inhibition of the DNA damage kinase DNA-PK, but not ATM, further inhibited foci loss in cohesin-depleted cells in G2. SMC1 depletion had no effect on DNA single-strand break repair in either G1 or late S/G2. Rad21 and SMC1 were recruited to sites of X-ray-induced DNA damage in G2-phase cells, but not in G1, and only when DNA damage was concentrated in subnuclear stripes, generated by partially shielded ultrasoft X-rays. Our results suggest that the cohesin complex contributes to cell survival by promoting the repair of radiation-induced DNA double-strand breaks in G2-phase cells in an ATM-dependent pathway.
Guo Li,
Lindsey C Aschenbach,
Jianyang Chen,
Michael P Cassidy,
David L Stevens,
Bichoy H Gabra,
Dana E Selley,
William L Dewey,
Richard B Westkaemper,
Yan Zhang
Keywords:
Chief, Infectious Diseases Section, Veterans Administration Medical Center, Boise, Idaho, USA.
Gram-positive aerobes are the most common organisms in hospitalized patients with skin and soft-tissue infections (SSTIs). Staphylococcus aureus is the most common Gram-positive aerobe among these infections with methicillin-resistant S. aureus (MRSA) the most common pathogen. The increased prevalence of MRSA has been noted in the hospital as well in the community setting. In choosing antimicrobial therapy, assessment of the infection and patient characteristics, such as animal exposure, travel history, underlying diseases, recent trauma, bites, burns, and water exposure, must be considered. Community-acquired MRSA strains are showing resistance to more antimicrobial classes, and b-lactam antibiotics can no longer be considered first-line therapy for community-acquired SSTIs. For more serious infections, there are several new antimicrobial options with good MRSA coverage, including linezolid, daptomycin, and tigecycline. Several agents are currently under clinical investigation or are being considered for approval by the US Food and Drug Administration, including ceftobiprole, dalbavancin, iclaprim, oritavancin, and telavancin.
David L Stevens,
Danielle King,
Ryan Laponis,
Kathleen Hanley,
Sondra Zabar,
Adina L Kalet,
Colleen Gillespie
New York University School of Medicine, Division of General Internal Medicine, Section of Primary Care, New York, NY, United States.
We implemented a pain assessment and management (PAM) curriculum for second year medical students and evaluated long-term skills retention compared to the prior year's class which did not receive the curriculum. The curriculum included pain pathophysiology, assessment and treatment instruction plus feedback on PAM practice with standardized patients. Both cohorts underwent a required end-of-third-year clinical skills examination. Intervention and control group performance on three pain cases (acute, chronic and terminal) was compared. The PAM curriculum was implemented 1.5years before the intervention cohort participated in the clinical skills exam. More intervention students (134/159, 84.3% response rate) obtained basic (87.2% vs. 76. %, p=.028) and comprehensive (75.2% vs. 60.9%, p=.051) descriptions of acute pain than control students (n=129/174, 74.1% response rate). Intervention students demonstrated superior skills for terminal pain, including: more often asking about impact on functioning (40.7% vs. 25.8%, p=.027), advising change of medication (97.3% vs. 38.7%, p<.001), and providing additional medication counseling (55. % vs. 27. %, p<.001). Virtually all students obtained basic descriptions of chronic (intervention vs. control, 98.1% vs. 96.1%, p=.367) and terminal (92.9% vs. 91.7%, p=.736) pain. Surprisingly, more control than intervention students obtained a comprehensive description of chronic pain (94.6% vs. 77.8%, p<.001) and asked about current pain medication in the terminal case (75.6% vs. 55. %, p=.004). Exposure to the curriculum resulted in durable increases in students' ability to perform PAM skills in patients with acute and terminal pain.
Veterans Affairs Medical Center, Boise, ID.
Clostridium sordellii, an anaerobic pathogen, has recently been associated with rapidly fatal infections following medically-induced abortions and injecting drug use. Patients with C. sordellii infection display few signs of inflammation such as fever, or redness and pain at the site of infection. We hypothesized that this could be due to reduced recognition of the organism by Toll-like receptors (TLRs) of the innate immune system. An ELAM-NF-kappaB luciferase reporter system in TLR-transfected HEK cells was used to measure TLR-dependent recognition of washed, heat-killed C. sordellii and other pathogenic clostridial species. Results demonstrated that all clostridia were well recognized by TLR2 alone and that responses were greatest when TLR2 was co-expressed with TLR6. Further, isolated human monocytes produced the pro-inflammatory cytokine TNFalpha and the immunoregulator IL-10 in response to C. sordellii. In addition, C. sordellii-stimulated monocytes produced 30% less TNFalpha following treatment with an anti-TLR2 blocking antibody. These data demonstrate that innate immune recognition of, and response to, cell-associated components of C. sordellii and other clostridial pathogens are mediated by TLR2 in combination with TLR6. We conclude that the characteristic absence of inflammatory signs and symptoms in C. sordellii infection is not related to inadequate immune detection of the organism, but rather is attributable to a species-specific immune system dysfunction that remains to be elucidated.
Associate Chief of Staff, Research & Development Service, Veterans Affairs Medical Center, Boise, Idaho; and University of Washington School of Medicine, Seattle.
Keywords:
Department of Physics and Astronomy, University of Birmingham, UK.
In many radiotherapy situations patients are exposed to mixed field radiation. In particular in BNCT, as with all neutron beam exposures, a significant fraction of the dose is contributed by low LET gamma ray photons. The components of such a mixed field may show a synergistic interaction and produce a greater cell kill effect than would be anticipated from the independent action of the different radiation types. Such a synergy would have important implications for treatment planning and in the interpretation of clinical results. An irradiation setup has been created at the Medical Research Council in Harwell to allow simultaneous irradiation of cells by cobalt-60 gamma rays and plutonium-238 alpha-particles. The setup allows for variation of dose and dose rates for both sources along with variation of the alpha particle energy. A series of cell survival assays for this mixed field have been carried out using V79-4 cells and compared to exposures to the individual components of the field under identical conditions. In the experimental setup described no significant synergistic effect was observed.
Research & Development Service, Veterans Affairs Medical Center, 500 West Fort St.(Bldg. 45), Boise, ID 83702, USA. yongsheng.ma@va.gov
A gene unique to Streptococcus pyogenes, called vfr, that negatively regulates speB, an important extracellular proteinase, has been identified. Disruption of vfr markedly increased SpeB production in a clinical strain of S. pyogenes and relieved its growth phase dependency. These findings may provide important insights into the pathogenesis of invasive S. pyogenes infections.
Mesh-terms: Bacterial Proteins :: biosynthesis; DNA Transposable Elements; Exotoxins :: biosynthesis; Gene Expression Regulation, Bacterial; Gene Knockout Techniques; Humans; Mutagenesis, Insertional; Repressor Proteins :: genetics; Repressor Proteins :: physiology; Streptococcus pyogenes :: enzymology; Streptococcus pyogenes :: genetics; Streptococcus pyogenes :: physiology;
Veterans Affairs Medical Center, Boise, Idaho, USA and, Idaho State University School of Pharmacy, Pocatello, Idaho, USA.
Antibiotic resistance is an ever-increasing concern in the treatment of severe skin and skin-structure infections, pneumonia, bacteremia and other serious infections caused by methicillin-resistant Staphylococcus aureus, vancomycin-resistant S. aureus, group A Streptococcus and vancomycin-resistant Enterococcus. In this review, we summarize the current status of both US FDA-approved and investigational agents aimed at this group of pathogens. We also describe, in detail, the chemistry, mechanism of action, pharmacokinetic properties and spectrum of microbiological activity of iclaprim, a novel dihydrofolate reductase inhibitor recently awarded fast-track approval status by the FDA. Finally, we review the clinical efficacy of iclaprim compared with linezolid for skin and skin-structure infections as demonstrated in Phase III randomized, controlled trials, and comment on its potential role in the treatment of other severe infections with drug-resistant Gram-positive pathogens.
Guo Li,
Lindsey C Aschenbach,
Jianyang Chen,
Michael P Cassidy,
David L Stevens,
Bichoy H Gabra,
Dana E Selley,
William L Dewey,
Richard B Westkaemper,
Yan Zhang
Department of Medicinal Chemistry, Department of Pharmacology and Toxicology, Virginia Commonwealth University, 410 North 12th Street, P.O. Box 980540, Richmond, Virginia 23298-0540.
Opioid receptor selective antagonists are important pharmacological probes in opioid receptor structural characterization and opioid agonist functional study. Thus far, a nonpeptidyl, highly selective and reversible mu opioid receptor (MOR) antagonist is unavailable. On the basis of our modeling studies, a series of novel naltrexamine derivatives have been designed and synthesized. Among them, two compounds were identified as leads based on the results of in vitro and in vivo assays. Both of them displayed high binding affinity for the MOR (K(i) = .37 and .55 nM). Compound 6 (NAP) showed over 700-fold selectivity for the MOR over the delta receptor (DOR) and more than 150-fold selectivity over the kappa receptor (KOR). Compound 9 (NAQ) showed over 200-fold selectivity for the MOR over the DOR and approximately 50-fold selectivity over the KOR. Thus these two novel ligands will serve as leads to further develop more potent and selective antagonists for the MOR.
